Sonata Capital Group Inc. Maintains Stake in Clorox Co. (CLX)
Sonata Capital Group Inc. maintained its stake in shares of Clorox Co. (NYSE:CLX) during the second quarter, according to its most recent filing with the SEC. The fund owned 3,835 shares of the company’s stock at the end of the second quarter. Sonata Capital Group Inc.’s holdings in Clorox were worth $531,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently made changes to their positions in the stock. Bank of Montreal Can bought a new stake in shares of Clorox during the second quarter worth about $53,902,000. Prudential Financial Inc. increased its stake in shares of Clorox by 209.8% in the first quarter. Prudential Financial Inc. now owns 540,279 shares of the company’s stock worth $68,107,000 after buying an additional 365,910 shares in the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in shares of Clorox by 7.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,504,422 shares of the company’s stock worth $567,827,000 after buying an additional 313,224 shares in the last quarter. BlackRock Group LTD increased its stake in shares of Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock worth $200,775,000 after buying an additional 245,650 shares in the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of Clorox by 446.4% in the first quarter. Bessemer Group Inc. now owns 276,686 shares of the company’s stock worth $34,879,000 after buying an additional 226,050 shares in the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.
Clorox Co. (NYSE:CLX) traded down 0.69% during trading on Monday, hitting $124.32. 705,347 shares of the company were exchanged. Clorox Co. has a 12 month low of $117.08 and a 12 month high of $140.47. The stock’s 50-day moving average is $127.93 and its 200-day moving average is $130.05. The company has a market capitalization of $16.10 billion, a price-to-earnings ratio of 25.27 and a beta of 0.30.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.44 earnings per share. Equities research analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be issued a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 2.57%. The ex-dividend date is Monday, October 24th. Clorox’s payout ratio is 64.91%.
A number of analysts have issued reports on CLX shares. Atlantic Securities started coverage on shares of Clorox in a report on Tuesday, June 14th. They issued a “neutral” rating and a $138.00 price target on the stock. Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, July 5th. Goldman Sachs Group Inc. restated a “neutral” rating and issued a $131.00 target price (up from $125.00) on shares of Clorox in a report on Friday, July 15th. Deutsche Bank AG restated a “hold” rating and issued a $134.00 target price (up from $130.00) on shares of Clorox in a report on Sunday, July 24th. Finally, Jefferies Group restated a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $128.90.
In other news, COO Nikolaos A. Vlahos sold 925 shares of the stock in a transaction dated Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of the stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $131.14, for a total transaction of $673,535.04. Following the completion of the sale, the senior vice president now owns 15,384 shares of the company’s stock, valued at $2,017,457.76. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.